Table 1.
Patient demographics at study enrollment.
| Characteristic | Mild/Moderate BPD (n = 8) |
Severe BPD (n = 17) |
p-Value |
|---|---|---|---|
| Gestational age (GA) at birth, weeks (mean ± SD) | 25.84 ± 2.64 | 25.39 ± 1.38 | 0.584 |
| GA at sample collection, weeks (mean ± SD) | 30.75 ± 5.86 | 33.26 ± 6.02 | 0.337 |
| Birth weight, grams (mean ± SD) | 704 ± 108 | 706 ± 162 | 0.981 |
| Day of life (mean ± SD) | 37 ± 31 | 60 ± 40 | 0.182 |
| Male sex, % (n) | 50 (4) | 47 (8) | >0.999 |
| FiO2 at sample collection (mean ± SD) | 0.25 ± 0.05 | 0.35 ± 0.10 | 0.010 |
| Antenatal steroids exposure, % (n) 1 | 75 (6) | 76 (13) | 0.289 |
| Delivered via C-section, % (n) | 75 (6) | 88 (15) | 0.289 |
| Racial/Ethnic Group, % (n) | |||
| Non-Hispanic White | 63 (5) | 53 (9) | 0.508 |
| Non-Hispanic Black | 25 (2) | 6 (1) | 0.289 |
| Hispanic | 0 (0) | 18 (3) | 0.008 |
| Asian | 13 (1) | 18 (3) | 0.070 |
| More than one race | 0 (0) | 6 (1) | 0.008 |
1 Any antenatal steroids exposure (1 or more doses received by mother before birth), values in bold indicate p = 0.05.